Exelixis, Inc. $EXEL Shares Bought by Three Seasons Wealth LLCMarket Beat·Jul 16 at 04:44 AMEXEL-2.03%
Is Exelixis (EXEL) Fully Valued On Its STELLAR 303 Trial Update?Simplywall·Jun 26 at 02:54 PMEXEL-2.03%
This PVH Analyst Turns Bearish; Here Are Top 3 Downgrades For Thursdaybenzinga_article·Jun 25 at 09:17 AMEXEL-2.03%ARI-1.45%
Citizens Jmp Forecasts Strong Price Appreciation for Exelixis (NASDAQ:EXEL) StockMarket Beat·Jun 24 at 08:06 AMEXEL-2.03%
Exelixis Colorectal Cancer Data Underwhelms: Gerberry Maintains Sell/Underperform with Price Target Below Current Share PriceTip Ranks·Jun 23 at 04:16 AMEXEL-2.03%BAC+0.65%
Exelixis says STELLAR-303 trial misses statistical significance for survival in metastatic colorectal cancer non-liver subgroupPUBT·Jun 22 at 07:02 AMEXEL-2.03%
How Investors Are Reacting To Exelixis (EXEL) CABOMETYX Neuroendocrine Tumor Phase 3 Win at ASCOSimplywall·Jun 17 at 09:59 AMEXEL-2.03%
Bank of New York Mellon Corp Cuts Position in Exelixis, Inc. $EXELMarket Beat·Jun 9 at 02:09 AMEXEL-2.03%GS-D+5.00%
Commonwealth Equity Services LLC Sells 259,643 Shares of Exelixis, Inc. $EXELMarket Beat·Jun 7 at 03:37 AMEXEL-2.03%
168,437 Shares in Exelixis, Inc. $EXEL Purchased by WINTON GROUP LtdMarket Beat·Jun 6 at 06:33 AMEXEL-2.03%
Exelixis (NASDAQ:EXEL) Reaches New 52-Week High - Time to Buy?Market Beat·Jun 5 at 02:42 PMEXEL-2.03%
